Zusammenfassung
„Sutureless“- bzw. „Rapid-deployment“-Aortenklappen sind eine wertvolle Bereicherung des herzchirurgischen Armamentariums. Die ersten klinischen Ergebnisse sind vielversprechend, bedürfen aber noch der weiteren Validierung mit größeren Zahlen in gut designten Studien in den nächsten Jahren. Sie erlauben im Rahmen der interdisziplinären Heart-Team-Besprechungen für Patienten mit Grenzindikationen, einen „dritten Weg“ abseits von Transkatheter-Aortenklappenimplantation und konventionellem Klappenersatz einzuschlagen. Dies allerdings vorzugsweise über echte minimalinvasive Zugänge, um bei reduzierter operativer Last dennoch die Vorzüge der sorgfältigen Entkalkung und der sicheren chirurgischen Implantation mit bewährten biologischen Substituten und gesicherter Langzeitfunktion anbieten zu können.
Abstract
Sutureless or rapid deployment valves have emerged as valuable supplements to the cardiac surgery portfolio. The first clinical results are promising but require validation within the coming years with larger numbers of patients enrolled in adequately designed studies. Within the heart team approach they enable patients with borderline indications for one or the other measure, a third option aside from transcatheter aortic valve implantation (TAVI) and conventional aortic valve replacement. This, however, is preferably carried out in combination with a truly minimally invasive approach in order to be able to provide implantation of a reliable biological valve with proven long-term patency and to reduce the procedural burden for the patient while utilizing the advantages of a thorough decalcification.
Notes
Kallenbach K; persönl. Mitteilung, Juni 2017
Literatur
Sian K, Li S, Selvakumar D, Mejia R (2017) Early results of the Sorin® Perceval S sutureless valve: systematic review and meta-analysis. J Thorac Dis 9(3):711–724. doi:10.21037/jtd.2017.03.24
Barnhart GR, Accola KD, Grossi EA, Woo YJ, Mumtaz MA, Sabik JF, Slachman FN, Patel HJ, Borger MA, Garrett HE Jr, Rodriguez E, McCarthy PM, Ryan WH, Duhay FG, Mack MJ, Chitwood WR Jr, TRANSFORM Trial Investigators (2017) TRANSFORM (Multicenter Experience With Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement) US clinical trial: Performance of a rapid deployment aortic valve. J Thorac Cardiovasc Surg 153(2):241–251.e2. doi:10.1016/j.jtcvs.2016.09.062
Bourguignon T, El Khoury R, Candolfi P, Loardi C, Mirza A, Boulanger-Lothion J, Bouquiaux-Stablo-Duncan AL, Espitalier F, Marchand M, Aupart M (2015) Very long-term outcomes of the carpentier-edwards perimount aortic valve in patients aged 60 or younger. Ann Thorac Surg 100(3):853–859. doi:10.1016/j.athoracsur.2015.03.105
Johnston DR, Soltesz EG, Vakil N, Rajeswaran J, Roselli EE, Sabik JF 3rd, Smedira NG, Svensson LG, Lytle BW, Blackstone EH (2015) Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg 99(4):1239–1247. doi:10.1016/j.athoracsur.2014.10.070
Lootens L, Verbeke J, Martens T, Philipsen T, Caes F, Van Belleghem Y, Van Nooten G, François K, De Bacquer D, Bove T (2017) Ten-year results of aortic valve replacement with first-generation Mitroflow bioprosthesis: is early degeneration a structural or a technical issue? Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezx117
Alavi SH, Groves EM, Kheradvar A (2014) The effects of transcatheter valve crimping on pericardial leaflets. Ann Thorac Surg 97(4):1260–1266. doi:10.1016/j.athoracsur.2013.11.009
Sulženko J, Toušek P, Kočka V, Bednář F, Línková H, Petr R, Laboš M, Widimský P (2017) Degenerative changes and immune response after transcatheter aortic valve implantation. Comparison with surgical aortic valve replacement. J Cardiol 69(2):483–488. doi:10.1016/j.jjcc.2016.03.009
Barbanti M, Tamburino C (2016) Late degeneration of transcatheter aortic valves: pathogenesis and management. EuroIntervention 12(Y):Y33–Y36. doi:10.4244/EIJV12SYA8
Glauber M, Gilmanov D, Farneti PA, Kallushi E, Miceli A, Chiaramonti F, Murzi M, Solinas M (2015) Right anterior minithoracotomy for aortic valve replacement: 10-year experience of a single center. J Thorac Cardiovasc Surg 150(3):548–556.e2. doi:10.1016/j.jtcvs.2015.06.045
Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Ihlberg L, Neumann FJ, Tarantini G, Zamarano JL, Vahanian A (2017) SOURCE 3 registry: design and 30-day results of the european postapproval registry of the latest generation of the SAPIEN 3 transcatheter heart valve. Circulation 135(12):1123–1132. doi:10.1161/circulationaha.116.025103
Villa E, Clerici A, Messina A, Testa L, Bedogni F, Moneta A, Donatelli F, Troise G (2016) Risk factors for permanent pacemaker after implantation of surgical or percutaneous self-expanding aortic prostheses. J Heart Valve Dis 25(6):663–671
Bouhout I, Mazine A, Rivard L, Ghoneim A, El-Hamamsy I, Lamarche Y, Carrier M, Demers P, Bouchard D (2017) Conduction disorders after sutureless aortic valve replacement. Ann Thorac Surg 103(4):1254–1260. doi:10.1016/j.athoracsur.2016.07.044
Greason KL, Lahr BD, Stulak JM, Cha YM, Rea RF, Schaff HV, Dearani JA (2017) Long-term mortality effect of early pacemaker implantation after surgical aortic valve replacement. Ann Thorac Surg:. doi:10.1016/j.athoracsur.2017.01.083
Yanagawa B, Cruz J, Boisvert L, Bonneau D (2016) A simple modification to lower incidence of heart block with sutureless valve implantation. J Thorac Cardiovasc Surg 152(2):630–632. doi:10.1016/j.jtcvs.2016.02.034
Siemieniuk RA, Agoritsas T, Manja V, Devji T, Chang Y, Bala MM, Thabane L, Guyatt GH (2016) Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis. BMJ 354:i5130. doi:10.1136/bmj.i5130
Beckmann A, Funkat AK, Lewandowski J, Frie M, Ernst M, Hekmat K, Schiller W, Gummert JF, Welz A (2016) German Heart Surgery Report 2015: The Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 64(6):462–474. doi:10.1055/s-0036-1592124
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
J.M. Albes gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine vom Autor durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Albes, J.M. „Sutureless valves“ – Dichtung und Wahrheit. Z Herz- Thorax- Gefäßchir 31, 333–339 (2017). https://doi.org/10.1007/s00398-017-0169-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00398-017-0169-7
Schlüsselwörter
- Herzklappenprothesenimplantation
- Transkatheter-Aortenklappenimplantation
- Nahtlose Wiederherstellung
- Minimalinvasive chirurgische Methoden
- „Patency“